Edward P. Bowman - Concepedia

Author

Edward P. Bowman

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

E P Bowman, E. Bowman, E. P. Bowman, E. P. W. Bowman, E.P. Bowman, E.P.W. Bowman, Edward Bowman, Edward P Bowman, Edward P. Bowman

Publications

12.3K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Stanford University VA Palo Alto Health Care System Emory University National Institutes of Health

About

Edward P. Bowman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	20	7K
2	Cell Biology	9	9	2.8K
3	Allergy	2	2	152
4	Biochemistry	2	2	262
5	Natural Sciences	1	1	228

Edward P. Bowman

Publications

11.3K

Citations

H-Index

Page 1

	Year	Citations
Development, cytokine profile and function of human interleukin 17–producing helper T cells Nicholas J. Wilson, Katia Boniface, Jason R. Chan, Nature Immunology InflammationCytokineImmune Cell DevelopmentImmunologyT Cell Immunity	2007	2K
Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells Michelle A. Lowes, Toyoko Kikuchi, Judilyn Fuentes‐Duculan, Journal of Investigative Dermatology Th17 T CellsAutoimmune DiseaseMedicineT-regulatory CellImmune Regulation	2008	1.1K
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells Jonathan Sherlock, Barbara Joyce-Shaikh, Scott Turner, Nature Medicine InflammationRheumatologyAutoimmune DiseaseSpondyloarthritisImmunology	2012	1K
CCL27–CCR10 interactions regulate T cell–mediated skin inflammation Bernhard Homey, Harri Alenius, Anja Müller, Nature Medicine InflammationSkin InflammationImmunologyT Cell ImmunityCd4 T Cell Responses	2002	793
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category Dror Luger, Phyllis B. Silver, Jun Tang, The Journal of Experimental Medicine	2008	704
IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis Jason R. Chan, Wendy M. Blumenschein, Erin Murphy, The Journal of Experimental Medicine ImmunologyImmune RegulationDermatologyHuman PsoriasisImmunotherapy	2006	669
Hematopoietic Stem Cells Are Uniquely Selective in Their Migratory Response to Chemokines Douglas E. Wright, Edward P. Bowman, Amy J. Wagers, The Journal of Experimental Medicine	2002	519
CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells Eric J. Kunkel, Chang H. Kim, Nicole H. Lazarus, Journal of Clinical Investigation	2003	334
6-C-kine (SLC), a Lymphocyte Adhesion-triggering Chemokine Expressed by High Endothelium, Is an Agonist for the MIP-3β Receptor CCR7 James J. Campbell, Edward P. Bowman, Kristine Murphy, The Journal of Cell Biology	1998	323
Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors Iannis E. Adamopoulos, Cheng-Chi Chao, Richard Geissler, Arthritis Research & Therapy	2010	292

Page 1